| Autor: |
Sadi Khosroshahi N; Department of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran., Koulaeizadeh S; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Abdi A; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Akbarzadeh S; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Hashemi Aghdam SM; Department of Medicine, Faculty of Medicine, Islamic Azad University of Tabriz, Tabriz, Iran., Rajabi A; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Safaralizadeh R; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. |
| Abstrakt: |
Background: Long noncoding RNAs (lncRNAs) as critical molecules play an essential role in the development of cancers. In colorectal cancer (CRC), various lncRNAs are related to cell proliferation, apoptosis, migration, and invasion. LncRNA prostate cancer-associated transcript 1 ( PCAT-1 ), as an oncogenic factor, is a diagnostic biomarker that regulates cell proliferation, migration, invasion, and apoptosis. Methods: This study evaluated the relationship between PCAT-1 , CRC occurrence, and pathological features of Iranian patients. The studied samples included 100 colorectal tumor tissues and 100 adjacent healthy tissues of Iranian CRC patients. RNAs were extracted from cancerous and noncancerous tissues to synthesize complementary DNA. The expression level of PCAT-1 was assessed using the real-time PCR method, and the data analysis was assessed using SPSS software. Results: In this study, expression level of PCAT-1 in tumor tissue was significantly increased in Iranian patients, and pathological studies of the patients had no significant relationship with the PCAT-1 expression profile. Conclusion: Our results suggested that the high expression of PCAT-1 resulted in the occurrence of colorectal tumor tissues in Iranian patients, which can be considered a diagnostic biomarker in CRC. |
